0241.HK

Alibaba Health Information Technology Limited [0241.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

0241.HK Stock Summary

Earnings have grown 30.06% per last year.

EPS has increased from the previous year and become positive (Yearly statements)

EPS has been increasing for the past 3 quarters (Quarter statements)

Earnings are expected to fall -100% next year

0241.HK has less than 1 year of cash runway

Top 10 Correlated ETFs

0241.HK

Top 10 Correlated Stocks

0241.HK

In the News

0241.HK Financial details

Company Rating

Strong Buy

Market Cap

46.15B

Income

947.05M

Revenue

50.94B

Book val./share

1.19

Cash/share

0.89

Dividend

Dividend %

Employees

1.55K

Optionable

Shortable

Yes

Earnings

23 May 2024

P/E

100.7

Forward P/E

PEG

-2.21

P/S

2.17

P/B

3.01

P/C

2.93

P/FCF

105797.96

Quick Ratio

2.11

Current Ratio

2.74

Debt / Equity

0.01

LT Debt / Equity

EPS (TTM)

0.07

EPS next Y

EPS next Q

EPS this Y

-300.51%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

39.34%

Revenue Q/Q

-15.11%

EPS Q/Q

19.64%

SMA20

SMA50

SMA100

-40%

Inst Own

Inst Trans

ROA

ROE

ROC

Gross Margin

22%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

2.74-6.04

52W High

-56.5%

52W Low

+30.5%

RSI

Rel Volume

0.89

Avg Volume

40.15M

Volume

35.7M

Perf Week

-9.69%

Perf Month

-19.44%

Perf Quarter

-40.95%

Perf Half Y

-46.19%

Beta

1.023

Volatility

0.08%, 0.3%

Prev Close

-1.51%

Price

2.61

Change

-1.14%

0241.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0.46	0.8	1.17	1.53	1.98
Net income per share	-0.01	0	0.03	-0.02	0.04
Operating cash flow per share	0.04	0.05	0.08	0.03	0.02
Free cash flow per share	0.04	0.05	0.07	0.03	0.02
Cash per share	0.18	0.25	0.88	0.78	0.81
Book value per share	0.25	0.44	1.08	1.05	1.12
Tangible book value per share	0.25	0.43	1.07	0.96	1.04
Share holders equity per share	0.25	0.44	1.08	1.05	1.12
Interest debt per share	0.16	0.01	0	0.01	0.01
Market cap	83.23B	141.56B	245.95B	55.59B	67.05B
Enterprise value	84.65B	139.04B	234.35B	45.18B	56.21B
P/E ratio	-1.02K	-21.49K	705.55	-209.35	125.71
Price to sales ratio	16.33	14.75	15.85	2.7	2.51
POCF ratio	209.99	242.56	243.65	131	262.24
PFCF ratio	213.27	245.75	247.84	135.78	268.13
P/B Ratio	29.78	26.87	17.2	3.94	4.42
PTB ratio	29.78	26.87	17.2	3.94	4.42
EV to sales	16.61	14.49	15.1	2.2	2.1
Enterprise value over EBITDA	-898.83	-2.62K	4.49K	-41.97	-2.3K
EV to operating cash flow	213.57	238.24	232.16	106.47	219.85
EV to free cash flow	216.91	241.37	236.15	110.35	224.78
Earnings yield	0	0	0	0	0.01
Free cash flow yield	0	0	0	0.01	0
Debt to equity	0.61	0.01	0	0.01	0.01
Debt to assets	0.28	0.01	0	0.01	0
Net debt to EBITDA	-15.07	47.62	-222.47	9.67	442.84
Current ratio	1.02	1.92	4.18	2.81	2.74
Interest coverage	-3.51	-3.07	15.3	-287.93	-8.83
Income quality	-4.84	-88.61	2.9	-1.6	0.48
Dividend Yield	0.01	0.01	0.04	0	0
Payout ratio	-7.19	-313.54	25.6	-0.2	0.21
Sales general and administrative to revenue	0.04	0.02	0.02	0.02	0.01
Research and developement to revenue	0.04	0.03	0.03	0.04	0.03
Intangibles to total assets	0	0.01	0	0.06	0.05
Capex to operating cash flow	-0.02	-0.01	-0.02	-0.04	-0.02
Capex to revenue	0	0	0	0	0
Capex to depreciation	-1.53	-0.18	-0.43	-0.25	-0.09
Stock based compensation to revenue	0.04	0.03	0.03	0.02	0.01
Graham number	0.21	0.07	0.8	0.68	1
ROIC	-0.03	0.02	0	-0.08	0
Return on tangible assets	-0.01	0	0.02	-0.01	0.03
Graham Net	-0.06	0.1	0.69	0.49	0.5
Working capital	70.01M	2.4B	10.8B	8.74B	9.48B
Tangible asset value	2.71B	5.14B	14.22B	12.94B	14.03B
Net current asset value	58.34M	2.35B	10.74B	8.44B	9.31B
Invested capital	0.61	0.01	0	0.01	0.01
Average receivables	228.41M	344.99M	319.08M	414.8M	547.39M
Average payables	612.98M	1.38B	2.21B	3.04B	3.62B
Average inventory	519.01M	906.53M	1.34B	1.51B	1.83B
Days sales outstanding	26.18	12.34	7.38	9.15	7.89
Days payables outstanding	87.49	92.39	78.25	78.2	64.36
Days of inventory on hand	57.75	60.28	45.04	34.35	36.43
Receivables turnover	13.94	29.57	49.48	39.88	46.24
Payables turnover	4.17	3.95	4.66	4.67	5.67
Inventory turnover	6.32	6.05	8.1	10.62	10.02
ROE	-0.03	0	0.02	-0.02	0.04
Capex per share	0	0	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q2

Metric	2021-09-30	2022-03-31	2022-09-30	2023-03-31	2023-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0.69	0.83	0.85	1.13	0.96
Net income per share	-0.02	0	0.01	0.03	0.03
Operating cash flow per share	0.04	-0.01	0.04	-0.02	0.07
Free cash flow per share	0.04	-0.01	0.04	-0.02	0.07
Cash per share	0.84	0.78	0.83	0.8	0.89
Book value per share	1.04	1.05	1.11	1.12	1.19
Tangible book value per share	0.95	0.96	1.02	1.03	1.1
Share holders equity per share	1.04	1.05	1.11	1.12	1.19
Interest debt per share	0.01	0.01	0.01	0.01	0.01
Market cap	124.9B	55.62B	44.1B	67.37B	61.63B
Enterprise value	113.71B	45.21B	32.94B	56.53B	50.02B
P/E ratio	-134.73	-411.57	67.98	45.18	34.55
Price to sales ratio	13.35	4.96	3.83	4.41	4.76
POCF ratio	208.97	-320.86	87.5	-271.25	67.71
PFCF ratio	211.37	-306.45	88.33	-270.31	68.96
P/B Ratio	8.87	3.94	2.95	4.44	3.83
PTB ratio	8.87	3.94	2.95	4.44	3.83
EV to sales	12.15	4.03	2.86	3.7	3.86
Enterprise value over EBITDA	-194.19	-92.07	-1.38K	1.19K	183.76
EV to operating cash flow	190.25	-260.79	65.35	-227.6	54.95
EV to free cash flow	192.43	-249.08	65.97	-226.82	55.97
Earnings yield	0	0	0	0.01	0.01
Free cash flow yield	0	0	0.01	0	0.01
Debt to equity	0	0.01	0.01	0.01	0.01
Debt to assets	0	0.01	0	0	0
Net debt to EBITDA	19.11	21.21	467.19	-228.7	-42.65
Current ratio	2.73	2.81	2.79	2.74	3.01
Interest coverage	0	0	0	0	0
Income quality	-2.58	5.13	3.11	-0.67	2.04
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.02	0.02	0.02	0.01	0.01
Research and developement to revenue	0.03	0.04	0.03	0.02	0.02
Intangibles to total assets	0.06	0.06	0.06	0.05	0.05
Capex to operating cash flow	-0.01	0.05	-0.01	0	-0.02
Capex to revenue	0	0	0	0	0
Capex to depreciation	-0.29	-0.22	-0.13	-0.03	-0.65
Stock based compensation to revenue	0.02	0.02	0.01	0.01	0.01
Graham number	0.64	0.24	0.55	0.83	0.94
ROIC	-0.04	-0.05	0	0	0.01
Return on tangible assets	-0.01	0	0.01	0.02	0.02
Graham Net	0.51	0.49	0.52	0.5	0.59
Working capital	9.27B	8.74B	9.35B	9.48B	10.47B
Tangible asset value	12.87B	12.94B	13.79B	14.03B	14.95B
Net current asset value	9.02B	8.44B	9.17B	9.31B	10.3B
Invested capital	0	0.01	0.01	0.01	0.01
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	4.86	4.14	4.17	3.41	4.21
Days payables outstanding	50.89	35.35	36.69	28.18	30.86
Days of inventory on hand	21.15	15.53	15.74	15.95	15.41
Receivables turnover	18.53	21.74	21.57	26.37	21.35
Payables turnover	1.77	2.55	2.45	3.19	2.92
Inventory turnover	4.25	5.79	5.72	5.64	5.84
ROE	-0.02	0	0.01	0.02	0.03
Capex per share	0	0	0	0	0

0241.HK Frequently Asked Questions

What is Alibaba Health Information Technology Limited stock symbol ?

Alibaba Health Information Technology Limited is a HK stock and trading under the symbol 0241.HK

What is Alibaba Health Information Technology Limited stock quote today ?

Alibaba Health Information Technology Limited stock price is $2.61 today.

Is Alibaba Health Information Technology Limited stock public?

Yes, Alibaba Health Information Technology Limited is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 40.15M
Market Capitalization 46.15B
Employee 1.55K
CEO Mr. Difan Shen
Headquarters Causeway Bay,HK
IPO Date 1972-07-06
Website https://www.alihealth.cn

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark. In addition, it engages in the tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong.